Amniocentesis Transperitoneal

Transperitoneal amniocentesis: Procedure and its application

Transperitoneal amniocentesis, also known as transabdominal amniocentesis or transperitoneal amniocentesis, is a medical procedure that is widely used to diagnose various genetic disorders and fetal abnormalities.

The transperitoneal amniocentesis procedure involves inserting a thin needle into the uterus through the abdominal wall of the pregnant woman. The needle penetrates the skin, subcutaneous tissue and anterior abdominal wall, and then through the uterus to the amniotic cavity, which contains the fluid surrounding the fetus (amniotic fluid). A needle is then used to extract a small amount of amniotic fluid, which contains fetal cells and other biochemical markers.

Transperitoneal amniocentesis is usually performed between 15 and 20 weeks of pregnancy, although the timing of the procedure may vary depending on specific circumstances and medical indications. Before undergoing transperitoneal amniocentesis, a woman should undergo an ultrasound examination to determine the exact position of the fetus and amniotic sac.

The purpose of transperitoneal amniocentesis is to obtain information about genetic abnormalities of the fetus, such as Down syndrome, spinal muscular atrophy, fibrocystic tumor formation and other hereditary diseases. Amniotic fluid analysis can reveal the presence of chromosomal abnormalities, genetic mutations, and other fetal abnormalities.

However, it is worth noting that transperitoneal amniocentesis is an invasive procedure and is not without risks. Possible complications include preterm labor, infection, bleeding, fetal damage and risk of miscarriage. Therefore, before undergoing the procedure, it is necessary to carefully discuss the indications, benefits and risks with your doctor.

In conclusion, transperitoneal amniocentesis is an important tool in prenatal diagnosis to detect genetic abnormalities and hereditary diseases of the fetus. However, before undergoing the procedure, the benefits and risks must be carefully assessed based on the specific circumstances of each pregnancy. The decision to perform transperitoneal amniocentesis should be made jointly by the physician and the patient, taking into account all factors, including the mother's age, medical conditions and personal preferences.

Transperitoneal amniocentosis is a method for diagnosing pregnancy, which includes puncture of the fetal sac and collection of amniotic fluid to determine the presence of pathologies in the fetus. The procedure is carried out using a special needle, which is inserted through the mother's abdominal wall into the area of ​​the membranes. Transperitoneal amniocenosis is performed in the presence of certain indications, such as fetal pathology, high risk of pathology, severe chronic diseases of the mother, mother's age under 35 years, multiple pregnancy, etc. This research method is safe for the fetus and does not interfere with its physical and psychological development. The procedure for performing transperitoneal amniocentosis is possible only in specialized medical institutions where there is the necessary equipment, qualified doctors and appropriate permission to perform the procedure. The doctor diagnoses the condition of the fetus and decides whether the procedure is necessary. If there are no indications for amniocentesis, the procedure is not performed. Material is collected during transperitoneal amniocentesis from the second half of the fourth month of pregnancy and continues until birth. To make the collection of biomaterial less traumatic for the mother and fetus, local anesthesia is used. Also in some cases, it is possible to use endotracheal anesthesia. After the study is completed, the results of transperitoneal amniocentesis are sent to the doctor for further analysis. In general, this procedure can only be performed for medical reasons and in the absence of contraindications.